Cite
MLA Citation
Martin J van den Bent et al.. “Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.” Lancet oncology, vol. 22, no. 6, 2021, pp. 813–823. http://access.bl.uk/ark:/81055/vdc_100131050620.0x000023